IRADIMED CORPORATION (the 'Company” or 'Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and ...
Canada’s public drug plans should not pay for a new medication that slows cognitive decline in patients with Alzheimer’s disease because it’s not clear the expensive therapy provides clinically ...
Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...
Allspring Premier Large Company Growth Fund lagged its benchmark in Q4 2025 but posted strong yearly gains. Read the full ...
ICU Medical (NASDAQ:ICUI) reported fourth-quarter 2025 revenue of $536 million and said it delivered 2% organic growth in the period and 5% organic growth for the full year, as management pointed to ...
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that the last ...
Radimed Corp (IRMD) reports a 17% revenue increase and outlines future growth plans amid challenges in transitioning to new product lines.
The Allspring Large Cap Growth Fund underperformed the Russell 1000 Growth Index during the fourth quarter. Read more here.
ICU Medical Inc (ICUI) reports strong Q4 revenue and gross margins, while addressing integration hurdles and tariff impacts.
Mortgage repayment calculator: How much extra you could be paying now the cash rate is 3.85 per cent
The Reserve Bank of Australia (RBA) has hiked interest rates by 0.25 of a percentage point, the first rise since November 2023. That means the cash rate is now 3.85 per cent. It was a move widely ...
SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results